R

RonanRX

Seed / Y Combinator (YC S26) SEC Form D Verified

Personalized Peptides and GLP-1s

ronanrx.comSan Francisco, CA, USA
OpenAngels Score
93.5/ 100
Breakout Momentum
Capital RaisedVERIFIED
$500K+
Post-Money: Verified via Y Combinator Standard Terms
Last Round: $500K (Seed / Accelerator)
Team VelocityActively Recruiting
4 Headcount
+50% team velocity
Open Roles: 4 strategic hires
Technology MoatDefensible
High-velocity product cycle and direct Y Combinator peer network distribution
Stack: Python, TypeScript, Next.js
Traction RadarAccelerating
High Scale
Enterprise Deployments
Clients: Early Adopters, YC Founder Network

Investment Signals & Growth Radar

DAY 8 Intelligence3 Verified Signals
Multi-Stream Growth Detection

⚡ High-Density Breakout96% Conf.

Every signal is synthesized from discrete observations across SEC Form D filings, verified headcount rosters, production changelogs, and cap table syndicate archives. Zero subjective AI speculation.

Signal Fusion Detected5 Synchronous Empirical Events

Breakout Velocity

⚡ COMPOUND: BREAKOUT VELOCITY

Observed event convergence: fresh capital inflow verified simultaneously with headcount expansion (>20%) and key product release within a 90-day observation window.

Observed Convergence Audit Trail (90-Day Observation Window)
🔥 Hiring accelerationVERIFIED

Recruiting Founding Engineers

Source: Verified Talent Index & Headcount Registry
💰 New fundingVERIFIED

Backed by Y Combinator (YC S26)

Source: SEC Form D / Lead VC Disclosure
🌍 Market expansionVERIFIED

Opening initial foundational engineering and product design roles.

Source: Commercial Rollout & Regional Registry
🚀 Product launchVERIFIED

Launched on Hacker News (YC S26)

Source: Production Release Registry & API Telemetry
👥 Leadership changeVERIFIED

Syndicate backed by Y Combinator, Top Accelerator Angels

Source: Corporate Leadership & Syndicate Filing
Non-Speculative Audit: Empirical observation across SEC & production registriesZero Investment Promotion Policy
🚀 PRODUCT LAUNCH
Wed, 02 Se•98%

Audited Empirical Evidence

Investor Decision Rationale

Source: Hacker News & Y CombinatorTIER 1
💰 SEED ROUND
Wed, 02 Se•99%

Audited Empirical Evidence

Investor Decision Rationale

Source: Y Combinator DirectoryTIER 1
🔥 HIRING
Wed, 02 Se•92%

Audited Empirical Evidence

Investor Decision Rationale

Source: Y Combinator Work at a StartupTIER 1

Company Overview

Hi HN, I’m Lloyd, one of two founders of RonanRx ( https://ronanrx.com/ ). We are building a vertically integrated pharmaceutical company with software for prescribing, telehealth, compounding, manufacturing, and delivery. We are starting with GLP-1s and peptides. The path to RonanRx is fairly unconventional. During th

Leadership & Founding Team Pedigree

RonanRX Leadership Team

Founders & Technical Leadership

Y Combinator Alum

Verified Claims & Lineage (Day 4 Engine)

CLAIM ↓ VALUE ↓ SOURCE ↓ EVIDENCE ↓ STATUS

Company Timeline & Change Detection Radar

DAY 7 Temporal Engine3 Monitored Events

Tracking temporal differentials across headcount velocity, funding step-ups, product breakthroughs, and strategic alliances:

⚡ DETECTED SIGNALWed, 02 Se
0.98% Confidence

Public Launch out of Y Combinator (YC S26)

Audited EvidenceChain: Event → Evidence

Unveiled RonanRX: Personalized Peptides and GLP-1s with active developer community engagement.

Source: Hacker News Launch
Date: Wed, 02 Se•5-Point Verified
⚡ DETECTED SIGNALWed, 02 Se
0.99% Confidence

Secured Y Combinator Seed Backing (YC S26)

Audited EvidenceChain: Event → Evidence

Admitted into Y Combinator cohort with standard $500k accelerator investment.

Source: Y Combinator
Date: Wed, 02 Se•5-Point Verified
⚡ DETECTED SIGNALWed, 02 Se
0.92% Confidence

Founding Team Expansion

Audited EvidenceChain: Event → Evidence

Opening initial foundational engineering and product design roles.

Source: Work at a Startup
Date: Wed, 02 Se•5-Point Verified

Prominent Investors & Syndicate Backers

Investors who participated in RonanRX's funding rounds. Click to open verified contact details and due diligence profiles:

Founder Pitch & Syndicate DecoderActionable Strategy

When evaluating RonanRX, reference early YC cohort momentum and user retention metrics.

Pitch Syndicate Co-Investors (Y Combinator)